Clinical Trial Update: Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders [Phase 1]

View source ↗

Summary

This document reports a completed placebo-controlled Phase 1 pilot trial of mecamylamine for autism spectrum disorders conducted by Ohio State University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• Mecamylamine (mecamylamine)

Snippet

Sponsor: Ohio State University | Conditions: Autistic Disorder, Pervasive Developmental Disorder | Phase 1 | Status: COMPLETED